statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cantor Fitzgerald reissued their overweight rating on shares of Annexon (NASDAQ:ANNX - Free Report) in a research note published on Wednesday, Benzinga reports.
Other research analysts have also...

Cantor Fitzgerald Reaffirms "Overweight" Rating for Annexon (NASDAQ:ANNX)

BRISBANE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with...

Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Annexon added to 'Q2 Tactical Ideas List' at Wells Fargo

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Annexon Biosciences (ANNX Research Report) and Insmed...

Analysts Are Bullish on Top Healthcare Stocks: Annexon Biosciences (ANNX), Insmed (INSM)

Annexon, Inc. (NASDAQ:ANNX - Get Free Report) saw a large increase in short interest in March. As of March 15th, there was short interest totalling 2,490,000 shares, an increase of 27.7% from the...

Short Interest in Annexon, Inc. (NASDAQ:ANNX) Increases By 27.7%

HC Wainwright reaffirmed their buy rating on shares of Annexon (NASDAQ:ANNX - Free Report) in a research note published on Wednesday morning, Benzinga reports. The firm currently has a $30.00 price...

Annexon (NASDAQ:ANNX) Given "Buy" Rating at HC Wainwright

Annexon price target raised by $2 at JPMorgan, here's why

Needham  Company LLC reiterated their buy rating on shares of Annexon (NASDAQ:ANNX - Free Report) in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has a $16.00...

Annexon (NASDAQ:ANNX) Rating Reiterated by Needham & Company LLC

Annexon, Inc. (NASDAQ:ANNX - Free Report) - HC Wainwright issued their Q1 2024 earnings per share estimates for Annexon in a report issued on Wednesday, March 27th. HC Wainwright analyst A. Fein...

Research Analysts Issue Forecasts for Annexon, Inc.'s Q1 2024 Earnings (NASDAQ:ANNX)

Annexon (NASDAQ:ANNX  Get Free Report) had its target price boosted by equities researchers at Wells Fargo & Company from $11.00 to $12.00 in a research report issued to clients and investors...

Wells Fargo & Company Increases Annexon (NASDAQ:ANNX) Price Target to $12.00

Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in Brisbane, CA.

Volume	2.88M
52-Wk High	$8.40
52-Wk Low	$1.57

ANNX Annexon Inc

About

Feed

News

Sentiment

Earnings

Fundamentals